Category & trade
Primary
pharmaceutical-drugs · embed-ft 0.41
Tree path
Medical Health › Pharmaceutical Drugs
Group (tier-1)
Also (top-3)
cancer0.32
Tech stack
Analytics
CDN
Framework
Consent/CMP
AI readiness
AI training policy
allowed
Terms of Service
AI-bot protection
AI files
Compliance (GEO / GDPR)
TLD
Overview
Title
PADCEV® (enfortumab vedotin-ejfv) | Official Patient Site
Description
PADCEV® + pembrolizumab is approved in 2 types of certain bladder cancers. Please see full Patient Information, including risk of Serious Side Effects.
Final URL
Language
en (html)
Scanned at
2026-06-25 17:36:46